Get the Stockscreener App
2.23
0.45%
-0.01
After Hours:
2.36
0.13
+5.83%
Creative Medical Technology Holdings Inc stock is traded at $2.23, with a volume of 96,463.
It is down -0.45% in the last 24 hours and up +0.00% over the past month.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
See More
Previous Close:
$2.24
Open:
$2.215
24h Volume:
96,463
Relative Volume:
1.54
Market Cap:
$8.24M
Revenue:
$3,000
Net Income/Loss:
$-5.76M
P/E Ratio:
-1.2073
EPS:
-1.8471
Net Cash Flow:
$-5.59M
1W Performance:
+4.69%
1M Performance:
+0.00%
6M Performance:
+0.45%
1Y Performance:
-10.80%
1-Day Range:
$2.21
$2.32
1-Week Range:
$2.11
$2.49
52-Week Range:
$1.504
$6.25
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Name
Creative Medical Technology Holdings Inc
Sector
Industry
Phone
480-399-2822
Address
211 E. OSBORN RD., PHOENIX
Compare CELZ vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
2.23 | 8.24M | 3,000 | -5.76M | -5.59M | -1.8471 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Creative Medical Technology Holdings Inc Stock (CELZ) Latest News
Creative Medical Technology Holdings Inc (CELZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Creative Medical Technology Holdings Inc - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Institutional Confidence - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Creative Medical Technology Holdings Expands Project PHOENIX to Collect Health Data from Veterans Exposed to Toxic Hazards - geneonline.com
Creative Medical launches virtual platform for veteran burn pit study By Investing.com - Investing.com South Africa
CELZ Advances Project PHOENIX into Data Collection Phase - GuruFocus
Creative Medical Technology opens nationwide burn-pit data registry - Proactive financial news
Creative Medical Technology (CELZ) Slips 4.6% as Stock Approaches Key SupportDay Trade Opportunities - newsline.com
Small cap wrap: Blockmate Ventures, Aftermath Silver, Arizona Gold & Silver… - Proactive financial news
Creative Medical Technology Holdings Advances Project Phoenix into Nationwide Ai Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards - marketscreener.com
Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards - The Manila Times
AI project to map toxic burn pit exposure in 1,000 US veterans - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market SessionAlvotech (NASDAQ:ALVO), Anixa Biosciences - Benzinga
CELZ Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesFull Year Guidance - newsline.com
Anthropic Quietly Releases Claude Fable 5 to Public After Earlier ConcernsPreliminary Results - newsline.com
Hancock Whitney Q1 2026 Earnings: EPS Beats Estimates Modestly Amid Flat Revenue EnvironmentOperating Margin Analysis - newsline.com
CELZ Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentEarnings Revision Report - newsline.com
Spain Tourism Surges to Record as Travelers Shift from Middle EastShort-Term Outlook - newsline.com
Nuwellis Shares Sink After Pricing $6 Million Equity and Warrant Offering (NUWE) - Yahoo Finance
Pro-Dex Inc. (PDEX) Edges Higher as Shares Trade Near ResistanceHedge Fund Favorites - newsline.com
CELZ Q1 2026 Earnings: Loss Per Share Narrows, Topping Analyst EstimatesEarnings Revision Downgrade - The Legal Advocate
CELZ Q1 2026 Earnings: Narrower Q1 Loss Fails to Lift Shares as Market Focuses on Cash RunwayFinancial Health Score - newsline.com
CELZ PE Ratio & Valuation, Is CELZ Overvalued - Intellectia AI
EPS Creative Health Technology Group Limited Announces Management Changes, Effective May 31, 2026 - marketscreener.com
Creative Medical Technology (CELZ) Edges Lower by 0.22% as Stock Consolidates Between Key LevelsStock Surge Alerts - The Legal Advocate
MFA Financial Inc. 8.875% Senior Notes due 2029 (MFAN) Q1 2026 Earnings: EPS Falls Just Short of Estimates, Bond Price Edges HigherProfit Cycle Analysis - The Legal Advocate
MIRA Pharmaceuticals Inc. (MIRA) Slips 8.66% to $1.05 as Technicals Test Key SupportLinear Regression - newsline.com
CELZ Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline AdvancesProfit Guidance Range - The Legal Advocate
Critical Metals Corp (CRML) Slips 3.75% as Key Support Level Tests BuyersRSI Oversold Picks - The Legal Advocate
CELZ Stock Price, Quote & Chart | CREATIVE MEDICAL TECHNOLOGY (NASDAQ:CELZ) - ChartMill
Intercontinental Exchange (ICE) Edges Higher Amid Positive Volume TrendsLast Point Support - newsline.com
Creo Medical shares surge 27% on proposed sale of remaining European stake - Yahoo Finance
Japan Smaller Capitalization Fund (JOF) Edges Lower Amid Modest PullbackMAMA Signal - The Legal Advocate
Creative Medical Technology Holdings, Inc.Common Stock (NQ: CELZ - FinancialContent
Accel Entertainment (ACEL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Xtant Medical Q1 2026 Results: Revenue Guidance Raised, Balance Sheet Strengthened, Exclusive HEMOBLAST® Bellows Distribution Secured 12 - Minichart
QT Imaging Reports First Quarter 2026 Revenue of $6.5 Million - Business Wire
Incannex Healthcare Wins MedTech Breakthrough Award for Innovative Obstructive Sleep Apnea Drug IHL-42X - Minichart
Leading Breast Surgical Oncologist Dr. Barry Roseman to Serve as Senior Medical Advisor to QT Imaging - Business Wire
United States shares higher at close of trade; Dow Jones Industrial Average up 0.19% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.19% - Investing.com
CELZ (CreativeMed) EPS beats estimates but shares fall nearly 3% despite narrower losses.AI Stock Signals - Newser
Creative Medical Technology Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Creative Medical Technology Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Creative Medical Technology (NASDAQ: CELZ) posts Q1 2026 loss, details cash use - Stock Titan
How CreativeMed (CELZ) prepares for market disruptions | Q3 2025: Earnings Beat EstimatesTrend Analysis - newser.com
Governor Newsom announces $1B in private investment generated through California Competes Tax Credits, driving business expansion in key industry sectors - California State Portal | CA.gov
Creative Medical Technology Holdings Inc Stock (CELZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):